Dynavax Technologies
DVAX
#4881
Rank
NZ$3.09 B
Marketcap
NZ$26.38
Share price
0.03%
Change (1 day)
14.42%
Change (1 year)

P/S ratio for Dynavax Technologies (DVAX)

P/S ratio as of December 2025 (TTM): 5.47

According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.38. At the end of 2025 the company had a P/S ratio of 3.47.

P/S ratio history for Dynavax Technologies from 2004 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.47-43.7%
20246.16-20.77%
20237.78314.15%
20221.88-51.09%
20213.84-63.54%
202010.5-22.67%
201913.6-80.59%
201870.2-97.98%
2017> 100025045.31%
201613.8-95%
2015276418.98%
201453.216.11%
201345.8-14.64%
201253.6175.33%
201119.526.1%
201015.4708.02%
20091.91111.82%
20080.9025-93.74%
200714.4-80.83%
200675.21006.01%
20056.80-46.81%
200412.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Agenus
AGEN
1.04-80.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2.57-53.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.13-24.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5.31-2.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.94-9.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
2.34-57.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
2.26-58.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.17-60.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
4.96-9.33%๐Ÿ‡บ๐Ÿ‡ธ USA